BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33117973)

  • 1. Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine.
    Hernández-Mesa M; Monteau F; Le Bizec B; Dervilly-Pinel G
    Anal Chim Acta X; 2019 Mar; 1():100006. PubMed ID: 33117973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of structural characteristics of (un)conjugated steroid metabolites in their collision cross section value.
    Bressan C; Celma A; Alechaga É; Monfort N; Ventura R; Sancho JV
    Anal Chim Acta; 2023 May; 1254():341128. PubMed ID: 37005032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collision Cross Section (CCS) Database: An Additional Measure to Characterize Steroids.
    Hernández-Mesa M; Le Bizec B; Monteau F; García-Campaña AM; Dervilly-Pinel G
    Anal Chem; 2018 Apr; 90(7):4616-4625. PubMed ID: 29528626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion Mobility Spectrometry in Food Analysis: Principles, Current Applications and Future Trends.
    Hernández-Mesa M; Ropartz D; García-Campaña AM; Rogniaux H; Dervilly-Pinel G; Le Bizec B
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31349571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of very low-molecular weight metabolites by traveling wave ion mobility and its use in human urine samples.
    Kurilung A; Limjiasahapong S; Kaewnarin K; Wisanpitayakorn P; Jariyasopit N; Wanichthanarak K; Sartyoungkul S; Wong SCC; Sathirapongsasuti N; Kitiyakara C; Sirivatanauksorn Y; Khoomrung S
    J Pharm Anal; 2024 May; 14(5):100921. PubMed ID: 38799238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-ion mobility spectrometry-mass spectrometry analysis of multiple classes of steroid hormone isomers in a mixture.
    Rister AL; Dodds ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121941. PubMed ID: 31877426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs.
    Tejada-Casado C; Hernández-Mesa M; Monteau F; Lara FJ; Olmo-Iruela MD; García-Campaña AM; Le Bizec B; Dervilly-Pinel G
    Anal Chim Acta; 2018 Dec; 1043():52-63. PubMed ID: 30392669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion mobility-derived collision cross section database: Application to mycotoxin analysis.
    Righetti L; Bergmann A; Galaverna G; Rolfsson O; Paglia G; Dall'Asta C
    Anal Chim Acta; 2018 Jul; 1014():50-57. PubMed ID: 29523251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Profiling of Human Urine Samples Using LC-TIMS-QTOF Mass Spectrometry.
    Di Poto C; Tian X; Peng X; Heyman HM; Szesny M; Hess S; Cazares LH
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2072-2080. PubMed ID: 34107214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry.
    Paglia G; Astarita G
    Nat Protoc; 2017 Apr; 12(4):797-813. PubMed ID: 28301461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of collision cross section values obtained via travelling wave ion mobility-mass spectrometry and ultra high performance liquid chromatography-ion mobility-mass spectrometry: Application to the characterisation of metabolites in rat urine.
    Nye LC; Williams JP; Munjoma NC; Letertre MPM; Coen M; Bouwmeester R; Martens L; Swann JR; Nicholson JK; Plumb RS; McCullagh M; Gethings LA; Lai S; Langridge JI; Vissers JPC; Wilson ID
    J Chromatogr A; 2019 Sep; 1602():386-396. PubMed ID: 31285057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional Separations of Intact Phase II Steroid Metabolites Utilizing LC-Ion Mobility-HRMS.
    Davis DE; Leaptrot KL; Koomen DC; May JC; Cavalcanti GA; Padilha MC; Pereira HMG; McLean JA
    Anal Chem; 2021 Aug; 93(31):10990-10998. PubMed ID: 34319704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a rapid profiling method for the analysis of polar analytes in urine using HILIC-MS and ion mobility enabled HILIC-MS.
    King AM; Mullin LG; Wilson ID; Coen M; Rainville PD; Plumb RS; Gethings LA; Maker G; Trengove R
    Metabolomics; 2019 Jan; 15(2):17. PubMed ID: 30830424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Rapid, Targeted LC-IM-MS Method for Anabolic Steroids.
    Wedge A; Hoover M; Pettit-Bacovin T; Aderorho R; Efird E; Chouinard CD
    J Am Soc Mass Spectrom; 2023 Aug; 34(8):1708-1714. PubMed ID: 37390334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights of ion mobility spectrometry and its application on food safety and authenticity: A review.
    Te Brinke E; Arrizabalaga-Larrañaga A; Blokland MH
    Anal Chim Acta; 2022 Aug; 1222():340039. PubMed ID: 35934427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted glucocorticoid analysis using ion mobility-mass spectrometry (IM-MS).
    Neal SP; Wilson KM; Velosa DC; Chouinard CD
    J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():50-56. PubMed ID: 35469203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
    Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
    Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of phase-II metabolites of flavonoids by liquid chromatography-ion-mobility spectrometry-mass spectrometry.
    Chalet C; Hollebrands B; Janssen HG; Augustijns P; Duchateau G
    Anal Bioanal Chem; 2018 Jan; 410(2):471-482. PubMed ID: 29167932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory.
    Dubland JA
    J Mass Spectrom Adv Clin Lab; 2022 Jan; 23():7-13. PubMed ID: 34988541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of urinary metabolites of boldione by LC-MS/MS. Part I: Phase I metabolites excreted free, as glucuronide and sulfate conjugates, and released after alkaline treatment of the urine.
    Gómez C; Pozo OJ; Fabregat A; Marcos J; Deventer K; Van Eenoo P; Segura J; Ventura R
    Drug Test Anal; 2012 Oct; 4(10):775-85. PubMed ID: 23090723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.